South Korea
Industry
BMI is maintaining its forecast for South Korea's US$10.5bn pharmaceutical market despite changes to the medicine pricing and purchasing regime. The government is planning to reduce...
2010-02-16Industry
The value of South Korea's over-the-counter (OTC) medicine market is expected to increase from KRW2,513bn (US$1.97bn) in 2009 to KRW2,544bn (US$2.42bn) in 2010. Due to the strengthening...
2010-01-28Industry
Healthcare spending in South Korea is expected to increase from KRW75,117bn (US$58.9bn) in 2009 to KRW84,053bn (US$80.1bn) in 2010. Due to the strengthening won, this equates to growth...
2010-01-25Industry
In order to fully penetrate the world's largest medicine market, South Korea's Daewoong Pharmaceutical has established a US unit in the state of Maryland. The new venture will focus...
2010-01-19Industry
South Korea's drug companies spend over 40% of turnover on promotional, advertising and marketing activities. This contradicts one of BMI's core views for the pharmaceutical and healthcare...
2009-04-14Industry
A scientific paper on a diabetes gene therapy written by South Korean scientists in 2000 has been retracted by the prestigious journal Nature. BMI notes that this is the second time...
2009-04-03Industry
Boehringer Ingleheim is outpacing the South Korean over-the-counter (OTC) medicine sector. The German company's sales increased 1.9% in the first half of 2008, while most other competitors...
2008-08-13Industry
Ties between South Korea and Azerbaijan have been strengthened with a proposal for the creation of a joint venture to develop pharmaceuticals. The deal was brokered by the countries'...
2008-05-21


